The role of peripheral fatty acids as biomarkers for Alzheimer's disease and brain inflammation

Alzheimer's disease (AD) is one of the leading causes of dementia worldwide and it is seen frequently in the elderly. AD is characterized by amyloid beta (Ab) plaques burden, neurofibrillary tangles, neuroinflammation and neuronal loss with memory impairment being one of the first signs of the disease [1, 2]. Some people experience mild cognitive impairment (MCI) which is often considered a transition phase from normal aging to AD, and subjects diagnosed with MCI have an increased risk of developing AD.
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - Category: Biomedical Science Authors: Source Type: research